Progress toward development of an inhalation vaccine against botulinum toxin.

about

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.

P2860

Q35532054-3A8500D4-0718-4EEF-9D4E-B5F18E0DDF12 Q37128417-E8C8A811-E88E-484A-BFDB-E09F5565B6F5

P2860

Progress toward development of an inhalation vaccine against botulinum toxin.

Item

http://www.wikidata.org/entity/Q35843653

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Progress toward development of an inhalation vaccine against botulinum toxin.

@ast

Progress toward development of an inhalation vaccine against botulinum toxin.

@en

type

Item

label

Progress toward development of an inhalation vaccine against botulinum toxin.

@ast

Progress toward development of an inhalation vaccine against botulinum toxin.

@en

prefLabel

Progress toward development of an inhalation vaccine against botulinum toxin.

@ast

Progress toward development of an inhalation vaccine against botulinum toxin.

@en

P1476

Progress toward development of an inhalation vaccine against botulinum toxin.

@en

P2093

Jong-Beak Park

http://www.w3.org/2001/XMLSchema#string

Lance L Simpson

http://www.w3.org/2001/XMLSchema#string

P2860

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin

Bioterriorism: from threat to reality.

Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines

How botulinum and tetanus neurotoxins block neurotransmitter release.

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Clinical recognition and management of patients exposed to biological warfare agents.

Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs.

P304

477-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.3.4.477

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15270652

http://www.w3.org/2001/XMLSchema#string

Progress toward development of an inhalation vaccine against botulinum toxin.

about

P2860

P2860

Progress toward development of an inhalation vaccine against botulinum toxin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698